ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm
|
|
mvaugusta
|
147 |
69K |
0 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
147
|
69K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
RCE - the Best way to get lowest cost price and screw the shorter.
|
|
mvaugusta
|
6 |
2.3K |
1 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
6
|
2.3K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Investor Presentation - Spark Plus Healthcare Day
|
|
mvaugusta
|
7 |
3.1K |
4 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
7
|
3.1K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Need to push the IV dose higher
|
|
mvaugusta
|
26 |
10K |
0 |
21/10/22 |
21/10/22 |
ASX - By Stock
|
26
|
10K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
[VIDEO] RCE: is R327 the muti-billion dollar answer to super bugs?
|
|
mvaugusta
|
6 |
3.5K |
17 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
6
|
3.5K
|
17
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial of R327 I.V. - 6000mg Complete
|
|
mvaugusta
|
18 |
8.7K |
6 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
18
|
8.7K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mvaugusta
|
13 |
5.6K |
9 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
13
|
5.6K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mvaugusta
|
13 |
5.6K |
1 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
13
|
5.6K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
RCE Webinar
|
|
mvaugusta
|
12 |
5.1K |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
12
|
5.1K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
RCE Webinar
|
|
mvaugusta
|
12 |
5.1K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
12
|
5.1K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Dr Philip Sutton - V.P. of Translational Sciences
|
|
mvaugusta
|
17 |
8.7K |
19 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
17
|
8.7K
|
19
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
7 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
2.1K
|
649K
|
7
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
0 |
14/07/22 |
14/07/22 |
ASX - By Stock
|
2.1K
|
649K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Why popping today?
|
|
mvaugusta
|
2 |
1.1K |
3 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
2
|
1.1K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
0 |
10/06/22 |
10/06/22 |
ASX - By Stock
|
2.1K
|
649K
|
0
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
11 |
04/06/22 |
04/06/22 |
ASX - By Stock
|
2.1K
|
649K
|
11
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
3 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
2.1K
|
649K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
1 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
2.1K
|
649K
|
1
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
3 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
2.1K
|
649K
|
3
|
|
ASX - By Stock
|
RCE Biotech |
Re:
RCE Charts
|
|
mvaugusta
|
2.1K |
649K |
6 |
02/06/22 |
02/06/22 |
ASX - By Stock
|
2.1K
|
649K
|
6
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial R327 Advances to 4000mg
|
|
mvaugusta
|
15 |
8.3K |
8 |
31/05/22 |
31/05/22 |
ASX - By Stock
|
15
|
8.3K
|
8
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial R327 Advances to 4000mg
|
|
mvaugusta
|
15 |
8.3K |
4 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
15
|
8.3K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Phase I Clinical Trial R327 Advances to 4000mg
|
|
mvaugusta
|
15 |
8.3K |
1 |
24/05/22 |
24/05/22 |
ASX - By Stock
|
15
|
8.3K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Recce Pharmaceuticals (ASX:RCE): A multi-billion-dollar sepsis solution?
|
|
mvaugusta
|
27 |
17K |
1 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
27
|
17K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Recce Pharmaceuticals (ASX:RCE): A multi-billion-dollar sepsis solution?
|
|
mvaugusta
|
27 |
17K |
0 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
27
|
17K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Recce Pharmaceuticals (ASX:RCE): A multi-billion-dollar sepsis solution?
|
|
mvaugusta
|
27 |
17K |
0 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
27
|
17K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial
|
|
mvaugusta
|
20 |
8.5K |
4 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
20
|
8.5K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial
|
|
mvaugusta
|
20 |
8.5K |
2 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
20
|
8.5K
|
2
|
|